Table 2 Outcomes of the surgical candidates
Primary malignancy | Surgical treatment | Morbidity (%) | Mortality (%) | 1YSR*,% | Follow up, months† | |||
|---|---|---|---|---|---|---|---|---|
Excisional Op | Palliative Op | |||||||
Type 1 | Type 2 | Type 3 | Type 4 | |||||
Lung | 0 | 9 | 11 | 3 | 8.7 | 8.7 | 13.0 | 4.3 (0.7 - 20.1) |
Liver | 0 | 10 | 5 | 4 | 10.5 | 5.3 | 31.6 | 8.5 (0.6 - 45.7) |
Rectum | 0 | 7 | 2 | 0 | 11.1 | 0 | 0 | 3.3 (1.0 - 4.8) |
Kidney | 0 | 4 | 3 | 0 | 0 | 0 | 14.3 | 9.2 (5.0 - 26.2) |
Prostate | 0 | 1 | 5 | 0 | 50.0 | 0 | 16.7 | 5.4 (3.9 - 36.7) |
Colon | 0 | 3 | 2 | 0 | 20.0 | 0 | 80 | 33.4 (5.6 - 46.2) |
Breast | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 4.7 (4.5 - 10.4) |
MM‡ | 0 | 4 | 1 | 0 | 0 | 0 | 100 | 27.8 (17.5 - 53.7) |
Stomach | 0 | 3 | 1 | 0 | 0 | 0 | 0 | 4.3 (2.7 - 10.5) |
Uterus | 1 | 2 | 1 | 0 | 75 | 0 | 25.0 | 7.6 (2.1 - 40.4) |
Head/Neck | 1 | 2 | 1 | 0 | 50 | 0 | 50.0 | 26.8 (3.9 - 48.5) |
GB/Biliary | 0 | 1 | 1 | 1 | 66.7 | 33.3 | 0 | 4.5 (0.7 - 5.3) |
Esophagus | 0 | 2 | 1 | 0 | 33.3 | 0 | 33.3 | 2.3 (2.1 - 13.5) |
Mediastinal | 0 | 0 | 2 | 1 | 0 | 33.3 | 33.3 | 6.3 (0.5 - 32.3) |
Lymphoma | 0 | 1 | 2 | 0 | 33.3 | 0 | 66.7 | 60.9 (11.6 - 75.1) |
MPNST | 0 | 2 | 0 | 0 | 0 | 0 | 50.0 | 24.5 (3.1 - 45.9) |
Thyroid | 0 | 0 | 1 | 1 | 0 | 0 | 100 | 45.9 (17.1 - 74.7) |
Bladder | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2.7 |
Others | 0 | 1 | 2 | 1 | 0 | 0 | 25.0 | 6.8 (2.0 - 16.5) |
Total | 3 | 56 | 41 | 12 | 16.1 | 4.5 | 27.7 | 5.9 (0.5 - 75.1) |